Literature DB >> 18332985

Fibrolamellar hepatocellular carcinoma in pregnancy.

M W Louie-Johnsun1, P M Hewitt, D S Perera, D L Morris.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is rare in pregnancy but can enlarge rapidly under these circumstances. CASE OUTLINE: A 25-year-old woman was diagnosed with HCC of fibrolamellar type immediately post-partum. One year after liver resection the patient remains well. DISCUSSION: This is only the second report of fibrolamellar carcinoma occurring in pregnancy. Other types of hepatocellular carcinoma in pregnancy have generally demonstrated a poor outcome, probably secondary to hormonal changes and increased liver vascularity.

Entities:  

Year:  2003        PMID： 18332985      PMCID： PMC2020588          DOI： 10.1080/13651820310015310

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN： 1365-182X            Impact factor:   3.647


  10 in total

1.  Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis.

Authors:  P J Johnson; N Krasner; B Portmann; A L Eddleston; R Williams
Journal:  Gut       Date:  1978-11       Impact factor: 23.059

2.  Fibrolamellar carcinoma of the liver in pregnancy. A case report.

Authors:  D Kroll; M Mazor; H Zirkin; H Schulman; M Glezerman
Journal:  J Reprod Med       Date:  1991-11       Impact factor: 0.142

Review 3.  Hepatocellular carcinoma during pregnancy and its comparison with other pregnancy-associated malignancies.

Authors:  W Y Lau; W T Leung; S Ho; S K Lam; C Y Li; P J Johnson; R Williams; A K Li
Journal:  Cancer       Date:  1995-06-01       Impact factor: 6.860

4.  Term delivery after hepatocellular carcinoma resection in previous pregnancy.

Authors:  T T Hsieh; H C Hou; J J Hsu; C C Hsieh; L B Jeng
Journal:  Acta Obstet Gynecol Scand       Date:  1996-01       Impact factor: 3.636

5.  Hepatocellular carcinoma in Hong Kong: clinical study on 340 cases.

Authors:  W Shiu; G Dewar; N Leung; W T Leung; M Chan; M Tao; C Lui; C L Chan; W Y Lau; C Metreweli
Journal:  Oncology       Date:  1990       Impact factor: 2.935

6.  Hepatocellular carcinoma as a rare cause of an excessive increase in alpha-fetoprotein during pregnancy.

Authors:  M Entezami; R Becker; A Ebert; W Pritze; H Weitzel
Journal:  Gynecol Oncol       Date:  1996-09       Impact factor: 5.482

7.  Oral contraceptives, pregnancy, and focal nodular hyperplasia of the liver.

Authors:  L D Scott; A R Katz; J H Duke; D F Cowan; N F Maklad
Journal:  JAMA       Date:  1984-03-16       Impact factor: 56.272

8.  Pregnancy in a patient with fibrolamellar hepatocellular carcinoma.

Authors:  O Gemer; S Segal; E Zohav
Journal:  Arch Gynecol Obstet       Date:  1994       Impact factor: 2.344

9.  [Hepatocellular carcinoma in pregnancy].

Authors:  C Brucker; M Weiss; L Schweiberer; T Genz; V Maassen; G Debus-Thiede
Journal:  Geburtshilfe Frauenheilkd       Date:  1994-05       Impact factor: 2.915

10.  Hepatocellular carcinoma in a pregnant woman detected by routine screening of maternal alpha-fetoprotein.

Authors:  L B Jeng; W C Lee; C C Wang; M F Chen; T T Hsieh
Journal:  Am J Obstet Gynecol       Date:  1995-01       Impact factor: 8.661
  10 in total
  5 in total

1.  A young woman with liver cancer.

Authors:  Celina S Ang; Richard K Do; Ali Shamseddine; Eileen M O'Reilly; Ali Haydar; Ashwaq Al-Olayan; Walid Faraj; Fouad Boulos; Mohamed Naghy; Dorothy Makanjoula; Hassan Farran; Hassan Sibai; David Wehbe; David P Kelsen; Ghassan K Abou-Alfa
Journal:  Gastrointest Cancer Res       Date:  2013-01

Review 2.  Liver diseases in pregnancy: diseases not unique to pregnancy.

Authors:  Ashraf A Almashhrawi; Khulood T Ahmed; Rubayat N Rahman; Ghassan M Hammoud; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

3.  Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium.

Authors:  Celina S Ang; R Katie Kelley; Michael A Choti; David P Cosgrove; Joanne F Chou; David Klimstra; Michael S Torbenson; Linda Ferrell; Timothy M Pawlik; Yuman Fong; Eileen M O'Reilly; Jennifer Ma; Joseph McGuire; Gandhi P Vallarapu; Ann Griffin; Francesco Stipa; Marinela Capanu; Ronald P Dematteo; Alan P Venook; Ghassan K Abou-Alfa
Journal:  Gastrointest Cancer Res       Date:  2013-01

4.  A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma.

Authors:  Imane El Dika; Robert J Mayer; Alan P Venook; Marinela Capanu; Michael P LaQuaglia; Rachel Kobos; Allison F O'Neill; Joanne F Chou; Michele Ly; Celina Ang; Eileen M O'Reilly; John D Gordan; Ghassan K Abou-Alfa
Journal:  Oncologist       Date:  2020-05-26

5.  Hepatocellular Carcinoma Presenting with Obstructive Jaundice during Pregnancy.

Authors:  Huan-Wei Chen; Feng-Jie Wang; Jie-Yuan Li; Eric C H Lai; Wan Yee Lau
Journal:  Case Rep Surg       Date:  2014-08-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.